 PARIS and Cambridge, Mass., Oct. 31, 2022 GLOBE NEWSWIRE -- NANOBIOTIX Euronext : NANO NASDAQ: NBTX the Company, a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that Laurent Levy, co-founder and chairman of the executive board, and Bart Van Rhijn, chief financial officer, will participate in a fireside chat at the Jefferies London Healthcare Conference at 5:00 PM GMT12:00 PM ET on Tuesday, November 15, 2022. 